Reactivation of chagas disease after autologous hematopoietic stem cell transplantation

Claudia Marcela Chalela, Angela Maria Peña, Angela Maria Roa, David L. Reyes, Jennifer Paola Rueda, Luis Antonio Salazar, Manuel Rosales, Edgar David Gomez, Edgar Augusto Bernal, Claudia Lucia Sossa Melo

Producción científica: Artículos / NotasArtículo Científicorevisión exhaustiva

9 Citas (Scopus)

Resumen

Chagas disease (CD) is a protozoan zoonosis caused by Trypanosoma cruzi. Reactivation of CD occurs via drug-induced immunosuppression before and during transplantation. Here, we report the case of a 62-year-old man diagnosed with classic Hodgkin lymphoma who received highly aggressive conditioning chemotherapy before undergoing stem cell transplantation (SCT). The patient tested positive for CD in pre-transplantation evaluation. The patient exhibited persistent fever and elevated C-reactive protein levels before and after SCT, and was treated with antibiotics. Micro-Strout test showed evidence of trypomastigotes and he was treated with benznidazole until tested negative. Post-transplantation seropositive patients should be screened for possible reactivation.

Idioma originalInglés
Número de artículoe20200143
Páginas (desde-hasta)1-4
Número de páginas4
PublicaciónRevista da Sociedade Brasileira de Medicina Tropical
Volumen54
DOI
EstadoPublicada - 2021

Huella

Profundice en los temas de investigación de 'Reactivation of chagas disease after autologous hematopoietic stem cell transplantation'. En conjunto forman una huella única.

Citar esto